The results of the Türkiye R&D 500 survey have been announced! The results of the Turkish Time R&D 500 Survey 2024, one of…userSeptember 12, 2025
An Important Milestone in Our Global Journey: FDA Approval Our product, Aminocaproic Acid Injection USP, 5 g/20 mL (250 mg/mL), has…userAugust 29, 2025
denemedenemedenemedenemedenemedeneme We have signed an exclusive distribution agreement with Santhera Pharmaceuticals. GEN İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GEN) and Santhera…userAugust 13, 2025
We have signed a distribution agreement with IntraBio! The exclusive distrivution agreement between Gen İlaç ve Sağlık ve Sağlık Ürünleri Sanayi ve…userFebruary 17, 2025
Phase 2 Clinical Trial Results for GN-037 Topical Cream | Press Release GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream…userSeptember 25, 2024
2024 GEN Announces Phase 2 Trial Results of GN-037 Topical Cream As GEN, we announced the positive results of the Phase 2 clinical…userSeptember 25, 2024
